BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 2 days ago UP Fintech Holding Limited Reports Strong 2025 Results 2 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 2 days ago Cato Corporation 2025 Financial Results Summary 2 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 2 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 2 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 2 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 2 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 2 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 2 days ago UP Fintech Holding Limited Reports Strong 2025 Results 2 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 2 days ago Cato Corporation 2025 Financial Results Summary 2 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 2 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 2 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 2 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 2 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 2 days ago
ADVERTISEMENT
Market News

Fitbit is betting on Versa for a revival

Fitbit’s (FIT) foray into the competitive smartwatch space a few years ago was an effort to turn the table with respect to the declining market share and share price. However, despite impressing Wall Street analysts, the Fitbit Ionic failed to compete with the likes of Apple (AAPL) watch in the market. In a last-ditch attempt, […]

April 26, 2018 2 min read
Market News

Fitbit’s (FIT) foray into the competitive smartwatch space a few years ago was an effort to turn the table with respect to the declining market share and share price. However, despite impressing Wall Street analysts, the Fitbit Ionic failed to compete with the likes of Apple (AAPL) watch in the market. In a last-ditch attempt, […]

Fitbit’s (FIT) foray into the competitive smartwatch space a few years ago was an effort to turn the table with respect to the declining market share and share price. However, despite impressing Wall Street analysts, the Fitbit Ionic failed to compete with the likes of Apple (AAPL) watch in the market.

In a last-ditch attempt, the California-based company this month released a successor to Ionic brand, called ‘Versa,’ which is compatible with both Android and iOS devices. Versa, which is priced at $200, is $50 cheaper than Apple Series 1 and is said to be more comfortable than its predecessor.

Courtesy- Wikimedia Commons

Despite the low price, Versa boasts of a battery life of up to 4 hours and numerous other features including sleep tracking, distance tracking, heart rate monitoring and calorie count. Unlike Ionic, Versa has done away with a dedicated GPS and instead, depends on phone’s GPS. Versa’s USP is probably its newest feature that tracks female health, including ovulation and periods.

This feature will be made available to users next month onwards. Despite the successful launch of Ionic, CEO James Park had admitted that the product had failed to meet the aggressive financial goals set by the company.

Though Ionic carried many features currently present in Versa, it failed to appeal to the consumers. Fitbit is hoping to correct that part with this new launch. Separately, Fitbit is also making an effort to enter in the fast-growing healthcare space by acquiring a health startup Twine Health earlier this year

ADVERTISEMENT